Utah Medical Products (UTMD) Cash from Operations (2010 - 2026)

Utah Medical Products' Cash from Operations history runs 17 years deep, the most recent figure standing at 3109000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 30.35% year-over-year to 3109000.0; the TTM figure through Mar 2026 stood at 13337000.0 (down 4.86% YoY), while the FY2025 annual figure was 14692000.0, down 0.94% from the prior year.
• Cash from Operations was 3109000.0 for Q1 2026 at Utah Medical Products, down from 3477000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 6915000.0 in Q1 2023 to a low of 2762000.0 in Q2 2024.
• Historically, Cash from Operations has averaged 4474117.65 across 5 years, with a median of 4832000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations soared 37.04% in 2023, then plunged 44.92% in 2024.
• A 5-year view of Cash from Operations shows it stood at 5680000.0 in 2022, then slipped by 6.13% to 5332000.0 in 2023, then slumped by 44.92% to 2937000.0 in 2024, then advanced by 18.39% to 3477000.0 in 2025, then dropped by 10.58% to 3109000.0 in 2026.
• The last three Cash from Operations figures came in at 3109000.0 (Q1 2026), 3477000.0 (Q4 2025), and 3878000.0 (Q3 2025), per Business Quant data.